- Home
- CRDF vs GGT Comparison
CRDF vs GGT Comparison
Compare CRDF & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- GGT
- Stock Information
- Founded
- CRDF 1999
- GGT 1994
- Country
- CRDF United States
- GGT United States
- Employees
- CRDF N/A
- GGT N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- GGT Trusts Except Educational Religious and Charitable
- Sector
- CRDF Health Care
- GGT Finance
- Exchange
- CRDF Nasdaq
- GGT Nasdaq
- Market Cap
- CRDF 144.4M
- GGT 152.3M
- IPO Year
- CRDF N/A
- GGT N/A
- Fundamental
- Price
- CRDF $2.20
- GGT $4.26
- Analyst Decision
- CRDF Strong Buy
- GGT
- Analyst Count
- CRDF 5
- GGT 0
- Target Price
- CRDF $11.10
- GGT N/A
- AVG Volume (30 Days)
- CRDF 762.3K
- GGT 59.7K
- Earning Date
- CRDF 11-06-2025
- GGT 01-01-0001
- Dividend Yield
- CRDF N/A
- GGT 15.56%
- EPS Growth
- CRDF N/A
- GGT N/A
- EPS
- CRDF N/A
- GGT 0.83
- Revenue
- CRDF $545,000.00
- GGT N/A
- Revenue This Year
- CRDF N/A
- GGT N/A
- Revenue Next Year
- CRDF N/A
- GGT N/A
- P/E Ratio
- CRDF N/A
- GGT $6.90
- Revenue Growth
- CRDF N/A
- GGT N/A
- 52 Week Low
- CRDF $1.90
- GGT $4.32
- 52 Week High
- CRDF $5.64
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- CRDF 52.58
- GGT 48.98
- Support Level
- CRDF $1.99
- GGT $4.22
- Resistance Level
- CRDF $2.13
- GGT $4.34
- Average True Range (ATR)
- CRDF 0.10
- GGT 0.05
- MACD
- CRDF 0.04
- GGT -0.01
- Stochastic Oscillator
- CRDF 78.69
- GGT 29.17
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.